Studies Pipeline

Adipeau maintains an active program of observational cohorts and clinical studies. Studies listed below are declared prospectively — before completion of follow-up — to document our evidence pipeline with full transparency. Where externally registered, the registry link is provided.

RCT-3

Skin Laxity Study

Registered
Ongoing
Population Product Follow-up N Registry
Women aged 45–75 with overt skin laxity on legs Strength Gel 3 months Enrolling (target: 30) ISRCTN11066382

Details

Purpose To evaluate contour uniformity changes in subjects older than 45 with overt skin laxity on legs
Primary endpoint Change in laxity severity measured using the Merz Laxity Scale at baseline and 3 months
Measurement Blinded evaluators applying Merz Laxity Scale
Follow-up started 13 February 2026
Expected completion 14 October 2026
Listed on this page 13 April 2026

GLP1C-1

Post GLP-1 Weight Loss Cohort

Ongoing
Population Product Follow-up N
Individuals with prior GLP-1–associated weight loss, weight stabilized, with visible skin changes Strength Gel 3 and 6 months Enrolling (target: 30)

Details

Purpose To evaluate contour uniformity changes in subjects using GLP-1 medications during a period of Adipeau use
Primary endpoint Contour uniformity of face as manifested by vertical contour balance and horizontal contour continuity
Measurement In-clinic imaging and blinded evaluation.
Recruitment Partner clinics and targeted outreach
Follow-up started 30 March 2026
Expected completion 30 October 2026
Registry Not externally registered. Declared on this page prior to completion of follow-up.
Listed on this page 13 April 2026

POSC-1

PROVOKED Older Skin Cohort

Ongoing
Population Product Follow-up N
Women aged 40+ from the PROVOKED community Both 3 months Enrolled: 14

Details

Purpose To evaluate contour uniformity changes in subjects aged 50+ working for PROVOKED magazine
Primary endpoint Contour uniformity of face as manifested by vertical contour balance and horizontal contour continuity
Measurement Self-submitted photography, blinded evaluators
Follow-up started 2 April 2026
Expected completion 2 August 2026
Registry Not externally registered. Declared on this page prior to completion of follow-up.
Listed on this page 13 April 2026

BSEC-1

Breast Skin Exploratory Cohort

Ongoing
Population Product Follow-up N
Women aged 30+ seeking to improve breast skin strength Strength Gel 3 and 6 months Enrolling (target: 15)

Details

Purpose To explore changes in breast skin during a period of Adipeau use
Primary endpoint Exploratory — changes in breast skin texture, shape, and firmness
Measurement Self-submitted photography and self-evaluation
Follow-up started 1 December 2025
Expected completion 1 August 2026
Registry Not externally registered. Declared on this page prior to completion of follow-up.
Listed on this page 13 April 2026

NRC-1

Non-Responder Follow-Up Cohort

Ongoing
Population Product Follow-up N
Individuals using the product for 3+ months without desired outcomes Both 3 and 6 months Enrolling (target: 15)

Details

Purpose To evaluate whether subjects who reported dissatisfaction with prior Adipeau use show visible contour changes during a structured follow-up period
Primary endpoint Contour uniformity of face as manifested by vertical contour balance and horizontal contour continuity
Measurement Self-submitted photography, blinded evaluators
Follow-up started 13 April 2026
Expected completion 13 October 2026
Registry Not externally registered. Declared on this page prior to completion of follow-up.
Listed on this page 13 April 2026

Planned Pooled Analysis

Subjects from NRC-1, GLP1C-1, and POSC-1 will be pooled and evaluated by blinded observers.

PRIMARY

Whether blinded observers can correctly determine which image is before and which is after

SECONDARY

Whether contour uniformity — horizontal and vertical — is improved

Studies not registered on an external registry were declared on this page prior to completion of follow-up. Page listing dates are verifiable via archived snapshots. Target enrollment (N) is listed for ongoing studies; actual evaluable N will be reported upon completion.

Ready to Try